SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-18-011206
Filing Date
2018-10-16
Accepted
2018-10-16 08:00:52
Documents
3
Period of Report
2018-10-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT mbvx8k_oct162018.htm 8-K 32591
2 PRESS RELEASE ex99-1.htm EX-99.1 10616
3 IMAGE ex99-1000.jpg GRAPHIC 4400
  Complete submission text file 0001654954-18-011206.txt   50626
Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121
Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37861 | Film No.: 181123551
SIC: 2834 Pharmaceutical Preparations